Starting a new medication comes with a lot of questions. That’s especially true for a medication like semaglutide that can affect your appetite and weight. Dosing can seem confusing, but the semaglutide weight loss dosage chart has a specific purpose: It lays out the dosing instructions in the FDA-approved prescribing information. These instructions include the appropriate starting dose and how to titrate (gradually step up) that dose to help limit side effects. Below, we’ll share more info about the semaglutide dosing chart and how a clinician (like one at Midi Health) can support you along the way.
When you’re starting (or thinking of starting) a GLP-1 medication, the dosing info can make your brain glitch a bit. How do you know (and who decides) when it’s time for you to step up to the next dose? That’s where the semaglutide weight loss dosage chart comes into play. If you’re prescribed Wegovy for weight management, your clinician will use this chart, which reflects the FDA-approved prescribing information, as a guide when starting and increasing your dose, while keeping in mind your individual health needs.
When you know where you are on the semaglutide titration schedule—and why—it can help you better understand your treatment. You’ll have a better sense of what to expect at each step and can handle side effects in a proactive way.
Read on for a clear, step-by-step read of the semaglutide weight loss dosage chart, an understanding of how the doses vary depending on which medication you take, practical rules for missed doses, and how a Midi clinician can guide you through the whole process.
Semaglutide Weight Loss Dosage Chart: The Wegovy Schedule
Wegovy is the form of semaglutide that’s FDA-approved for weight loss. Here’s the Wegovy dosage chart for the injectable form of the medication:
As you can see, you’ll typically increase your dose every 4 weeks (though there are exceptions). Not everyone will reach the highest dose: The maintenance dosage—meaning, the dose that you’re expected to continue with long-term—is usually 1.7 mg or 2.4 mg per week. The doses differ for oral forms of Wegovy.
Why Does the Semaglutide Dose Go Up So Slowly?
Your body needs time to get used to the medication. A slow ramp-up makes that easier and helps decrease the risk of side effects.
Semaglutide is a GLP-1 receptor agonist medication. It turns down the appetite centers in your brain so you have fewer cravings and eat less, and it delays gastric emptying. This means that it slows down digestion, keeping food in your stomach for a longer time before moving it along the digestive tract. That helps keep you fuller for longer.
Slower digestion can result in side effects like nausea, vomiting, abdominal distention and reflux, and/or diarrhea or constipation. If you start at a high dose, you’re more likely to experience these side effects in a severe way. About 15% of people who stopped a GLP-1 did so because they weren’t able to tolerate the side effects, according to one study. You could be at higher risk of stopping the medication if you start at a higher dose or increase it too quickly.
Also consider that this medication can have quite an impact on your appetite and desire to eat. Starting low lets you shift your eating habits while making sure you’re getting the nutrients you need for a healthy, energetic body.
Ozempic vs. Wegovy: Why the Dosage Charts Are Different
Ozempic and Wegovy both contain semaglutide as the active ingredient. However, their dosage charts differ because they are FDA approved for different indications. Here’s an overview:
- Ozempic is approved to treat type 2 diabetes, reduce the risk of cardiovascular events in adults with type 2 diabetes and heart disease, and reduce the risk of kidney dysfunction and disease in adults with type 2 diabetes and chronic kidney disease.
- Wegovy is approved for chronic weight management in adults with obesity or adults who are overweight with at least one weight-related health issue. It is also approved to reduce cardiovascular risk in adults with obesity/overweight and established cardiovascular disease, as well as to treat adults with noncirrhotic metabolic dysfunction-associated steatohepatitis, also known as MASH (injectable Wegovy only).
Ozempic’s dosage steps and maximum weekly dose differ from Wegovy’s, which is why their charts aren’t used interchangeably.
This is the schedule for the Ozempic injection in adults with type 2 diabetes. It’s shown for comparison only: Ozempic is not FDA-approved for weight management.
The key differences between the Wegovy and Ozempic dosage charts are that the maximum dose of Ozempic is 2 mg per week and the potential maintenance dose starts at 0.5 mg per week.
Another note: Wegovy also has an oral semaglutide version. (It’s approved for the same conditions as the injectable, with the exception of noncirrhotic MASH.) These tablets are available in four dosages: 1.5 mg, 4 mg, 9 mg, and 25 mg. Similar to the injection, you start at the lowest dose for 30 days and increase your dose every 30 days until reaching the 25 mg once-daily maintenance dose.
It's also important to note that this chart does not translate into a tirzepatide conversion. Other GLP-1-based medications have their own dosing guidelines. (That’s one more reason why it’s important to speak to a trained clinician before beginning any GLP-1!)
Finally, a quick note on compounded medications: The dosing charts in this article apply only to FDA-approved Wegovy and Ozempic. Compounded GLP-1 medications are not FDA-approved, have not been reviewed by FDA for safety, effectiveness, or quality, and do not follow these dosing charts.
What to Expect at Each Dose of Semaglutide
Everyone responds to semaglutide differently, and individual results vary from person to person. Here’s what some people notice as they progress through the Wegovy titration schedule:
0.25 mg (weeks 1 to 4):
How you may feel: When you first start on the medication and the dose is low, you may notice some subtle reduction in “food noise.” This refers to persistent, sometimes intrusive thoughts surrounding food. You may also feel a bit fuller sooner during meals and have mild nausea or constipation that often improves over time.
0.5 mg (weeks 5 to 8):
How you may feel: Your appetite may feel noticeably lower, so you might start eating smaller portions. Cravings can take a dip, too, and you may find that high-fat, highly processed, or sugary foods are easier to skip.
1.0 mg (weeks 9 to 12):
How you may feel: In between meals, you may find you can go significantly longer without eating than before. You may also notice less impulse snacking.
1.7 mg (weeks 13 to 16):
How you may feel: You may reach a feeling of satisfying fullness more easily with smaller meals or snacks.
2.4 mg (month 5+):
How you may feel: This is considered the usual maintenance dose, so lower hunger and more fullness may feel like your new normal now.
In clinical trials, adults taking Wegovy 2.4 mg along with a reduced-calorie diet and increased physical activity lost an average of about 15% of their body weight after 1.5 to 2 years. Individual results vary. In a separate trial lasting about 3 years, Wegovy was associated with a 20% reduction in major adverse cardiovascular events among adults with obesity or overweight and established cardiovascular disease.
Finally, some important safety information to know: Wegovy and Ozempic carry a boxed warning about the possible risk of thyroid C-cell tumors, citing rodent studies and that use is considered in contraindicated in persons with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). Other serious risks can include pancreatitis, gallbladder problems, low blood sugar, kidney problems, and allergic reactions. It's also contraindicated in pregnancy. There's also a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) linked with GLP-1 RA meds. Review the full Prescribing Information and Medication Guide, and talk with your clinician about whether these medications are right for you.
What Should You Do if You Miss a Dose of Semaglutide?
It happens: Missing a dose of medication is a common experience. Generally, here’s what to do when that happens on the Wegovy injection:
- If you miss a dose and your next dose is more than 2 days away: Take the injection ASAP.
- If you miss a dose and your next dose is less than 2 days away: Wait and take the injection on your regularly scheduled day.
- If you miss two or more consecutive doses: Talk with your clinician. You may need to step back down to a lower dose to limit side effects.
- The rules are different for oral Wegovy, since it’s a daily medication: If you miss a dose of oral Wegovy, you should just skip that missed dose and take the next one the following day.
- The rules are also different for the Ozempic injection: If you miss a dose, take it as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and take your next dose on your regularly scheduled day.
Why Might a Clinician Slow Down or Change Your Ramp?
Guidelines exist for a reason, but they can’t predict how you’ll react to the medication in terms of side effects or weight loss. That’s why the decision about when to increase a semaglutide dose is made in consultation with a clinician.
Sometimes, a clinician will advise that you stay at a lower dose of semaglutide or temporarily decrease it if you’re having trouble tolerating the side effects and your body needs more time to adjust to the medication.
Or a clinician may have you stay at a particular dose if you’re continuing to lose weight at a safe, steady pace (typically 1 to 2 pounds per week). Losing weight too quickly can increase the risk of losing lean muscle mass alongside body fat. If you eventually hit a weight loss plateau, your dose can be evaluated and potentially increased to safely resume progress.
Some people reach their goal at a lower dose than others, and that can become their semaglutide maintenance dose. The general thinking is that the lowest effective dose is the best.
Remember: Semaglutide dose changes should always be done in a conversation with your clinician, not self-adjusted in reaction to a chart that you come across online.
Semaglutide Dosing Considerations for Women in Perimenopause and Menopause
So much can change about your body during midlife, both how it looks and how you feel in it. Shifting hormones and fluctuating estrogen levels, along with age-related decreases in muscle mass, change your body composition, including more fat buildup in your belly area.
And yes, all of that can negatively affect your mood and how you feel about yourself day to day. For women who are eligible, semaglutide combined with healthy lifestyle changes is one possible treatment strategy to address some of these midlife changes. The med is indicated for individuals meeting specific BMI criteria (such as a BMI of 30 or higher, or 27 or higher with weight-related health conditions), rather than as a cosmetic fix. One small study found that low doses of semaglutide had similar effects on body weight and fat in postmenopausal and premenopausal women, though more research is needed.
There are advantages to talking with a menopause-informed clinician, like one at Midi, about your weight loss goals in midlife, such as:
- Hormone therapy and other therapies may be part of the treatment conversation, and midlife-informed clinicians can coordinate both that and GLP-1s like semaglutide.
- Foundational lifestyle habits are prioritized. Clinicians emphasize that sustainable lifestyle changes—including a nutrition-rich diet, regular physical exercise, and adequate restorative sleep—are essential and foundational for getting the best outcomes while taking a GLP-1 medication.
- Clinicians are also well-versed in perimenopause symptoms—some of which are similar to semaglutide side effects—and they can suss out what may be driving your symptoms and help you find relief.
- Retaining muscle mass is a concern both in menopause and while taking weight loss medication, and your clinician can help you focus on this while overseeing your dose ramp-up. They can also give you guidance on maintaining a balanced diet and getting plenty of fiber and protein, both of which are a necessity when taking a GLP-1.
All in all, when you’re taking a semaglutide medication during midlife, it’s a time when more support may be needed—but that’s not a reason to expect less success.
How to Talk With a Clinician About Your Semaglutide Dose
Having an open discussion with your clinician about semaglutide or another GLP-1 will help you get the most out of the medication. You should feel free to ask about anything, but here are a few questions to start with:
- Am I a candidate for this medication, and have I already adopted the lifestyle elements that support success?
- What dose am I taking and why?
- When will the dose be increased?
- If I have side effects, what can I handle on my own at home and when should I call you?
- What should I do if I miss a dose?
It’s a good idea to keep a record of your dose and symptoms (what type of side effects you’re having and their intensity). This way, you’ll know better what to expect during dose increases or right after each injection, and you’ll have info at hand to discuss at your follow-ups.
Midi clinicians are here to help you navigate midlife weight changes with expert support. Together, you can discuss care solutions such as diet and exercise and, if you’re eligible and it’s clinically appropriate, treatments like GLP-1s. Talk with a Midi clinician about midlife weight care.
Key Takeaways
- Wegovy injection is started at a low dose and typically increased every 4 weeks until reaching a maintenance dose.
- A slow ramp-up in dose lets your body adjust to changes in appetite and digestion, which may help decrease risk of side effects like nausea and vomiting.
- Midi clinicians provide individualized care and follow FDA-approved labeling when prescribing. They may recommend slowing or pausing dose increases depending on how you feel on the medication.
- Clinician-led GLP-1 care helps you with side-effect management, lab monitoring, dose titration, and maintenance plans.
Frequently Asked Questions (FAQs)
Where do I inject semaglutide?
You can inject semaglutide subcutaneously (under the skin) of your abdomen, thigh, or upper arm.
What is the highest dosage of semaglutide?
The Wegovy HD pen offers the highest dose of injectable semaglutide at 7.2 mg. The regular Wegovy injection is offered at a highest dose of 2.4 mg.
At what dosage does semaglutide start working?
Some people notice changes in appetite at the lowest dose, but the starting dose is meant to help your body adjust and isn’t the dose intended for long-term weight management. Higher maintenance doses are expected to have a bigger impact on appetite and cravings, as well as greater weight loss, compared with the starting dose.
What dosages does semaglutide come in?
Semaglutide is available as Ozempic (for type 2 diabetes) in 0.25 mg/0.5 mg/1.0 mg/2.0 mg weekly doses. Semaglutide is available as Wegovy injection in 0.25 mg/0.5 mg/1.0 mg/1.7 mg/2.4 mg doses, as well as the 7.2 mg Wegovy HD pen, and as Wegovy tablets in 1.5 mg/4 mg/9 mg/25 mg daily doses.
What is the maintenance dose of semaglutide after weight loss?
Wegovy (semaglutide) is available as a maintenance dose of 1.7 mg and 2.4 mg weekly injection, and as a 7.2 mg weekly injection (Wegovy HD) for some adults. Oral Wegovy has a maintenance dose of 25 mg daily.
This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any questions regarding a medical condition or before starting any new treatment.
If you’re in perimenopause or menopause and want guidance from clinicians who specialize in women’s midlife health, book a virtual visit with Midi today.
Hormonal change is at the root of dozens of symptoms women experience in the years before and after their period stops.
Our trained menopause specialists can help you connect the dots to guide you towards safe, effective solutions.
Whether you need personalized guidance or a prescription routine to tackle symptoms—including vaginal dryness and irritation, brain fog, hot flashes, sleep trouble, mood swings, and weight gain—we’ve got you covered.
Midi’s mission is to revolutionize healthcare for women at midlife, wherever they live and whatever their health story. We believe that starts with education, to help all of us understand our always-changing bodies and health needs. Our core values guide everything we do, including standards that ensure the quality and trustworthiness of our content and editorial processes. We’re committed to providing information that is up-to-date, accurate, and relies on evidence-based research and peer-reviewed journals. For more details on our editorial process, see here.





